Physician profile
Michael A Sermersheim
NPI 1770587487
$31,514.61
in general payments reported to CMS, 2019-2025
82 companies · $6,470 in 2025
The $6,470 reported for 2025 was more than what 87% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,137 · 2020: $3,788 · 2021: $3,163 · 2022: $4,690 · 2023: $4,582 · 2024: $4,685 · 2025: $6,470.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $15K · Travel and Lodging: $808 · Education: $296 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $19.98.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $14,612.53 |
| Travel and Lodging | $808.11 |
| Education | $296.44 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $19.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,896.90 | 2019-2025 | Botox, Duopa, Qulipta |
| Medtronic, INC. | $2,841.75 | 2021-2025 | Percept PC Brainsense, Sensight |
| Ucb, INC. | $1,904.34 | 2019-2025 | Briviact, Nayzilam, Rystiggo |
| Novartis Pharmaceuticals Corporation | $1,772.31 | 2019-2025 | |
| Mdd US Operations, LLC | $1,526.36 | 2019-2025 | Apokyn, Apokyn |
| Medtronic USA, INC. | $1,286.81 | 2019-2020 | |
| Teva Pharmaceuticals USA, INC. | $1,144.25 | 2019-2025 | Austedo Xr, Austedo Xr, Austedo |
| Neurocrine Biosciences, INC. | $974.06 | 2019-2025 | Ingrezza, Ongentys |
| Lilly USA, LLC | $972.08 | 2020-2025 | Kisunla, Amyvid, Emgality |
| Sunovion Pharmaceuticals INC. | $912.32 | 2019-2022 | |
| Jazz Pharmaceuticals INC. | $896.81 | 2019-2025 | Xywav, Epidiolex |
| Supernus Pharmaceuticals, INC. | $839.00 | 2019-2022 | |
| Acadia Pharmaceuticals INC | $756.50 | 2019-2025 | Nuplazid |
| Harmony Biosciences LLC | $701.08 | 2020-2025 | Wakix |
| Biogen, INC. | $692.70 | 2019-2024 | Vumerity, Tysabri, Avonex |
Show all 82 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eisai INC. | $692.50 | 2019-2025 | |
| Livanova USA, INC. | $654.85 | 2019-2025 | Vns Therapy Sentiva Model 1000 Generator |
| Amgen INC. | $622.30 | 2019-2025 | Aimovig, Uplizna |
| Lundbeck LLC | $576.82 | 2019-2025 | Vyepti |
| Sk Life Science, INC. | $571.74 | 2020-2025 | |
| Genentech USA, INC. | $557.57 | 2019-2025 | Ocrevus, Ocrevus Zunovo, Evrysdi |
| Alexion Pharmaceuticals, INC. | $547.25 | 2019-2025 | Ultomiris, Soliris |
| Pfizer INC. | $530.15 | 2019-2025 | |
| Amneal Pharmaceuticals LLC | $523.79 | 2019-2025 | Crexont, Rytary |
| Genzyme Corporation | $430.33 | 2019-2025 | |
| Argenx US, INC. | $390.10 | 2023-2025 | Vyvgart, Vyvgart Hytrulo |
| Catalyst Pharmaceuticals, INC. | $341.47 | 2022-2025 | Fycompa |
| Allergan, INC. | $338.72 | 2019-2021 | |
| Vanda Pharmaceuticals INC. | $337.57 | 2025 | Ponvory |
| Alnylam Pharmaceuticals INC. | $310.47 | 2019-2024 | Onpattro |
| Sumitomo Pharma America, INC. | $291.92 | 2023-2024 | Aptiom |
| Celgene Corporation | $263.37 | 2021-2025 | Zeposia |
| Acorda Therapeutics, INC | $234.59 | 2019-2023 | Ampyra, Inbrija |
| Tg Therapeutics, INC. | $191.50 | 2023-2025 | |
| Otsuka America Pharmaceutical, INC. | $188.62 | 2023-2025 | Nuedexta, Rexulti |
| Banner Life Sciences, LLC | $186.17 | 2022-2024 | |
| Emd Serono, INC. | $153.65 | 2019-2021 | |
| Avanir Pharmaceuticals, INC. | $146.39 | 2019-2021 | |
| Csl Behring | $130.66 | 2020-2025 | Hizentra |
| Tanabe Pharma America, INC. | $128.75 | 2021-2025 | Radicava |
| Adamas Pharmaceuticals, INC. | $120.83 | 2019-2021 | |
| Abbott Laboratories | $119.02 | 2019-2025 | Infinity |
| Neurelis, INC. | $114.04 | 2021-2025 | Valtoco |
| Scilex Pharmaceuticals INC. | $110.78 | 2024-2025 | |
| Arbor Pharmaceuticals, INC. | $105.11 | 2019-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $94.39 | 2023-2025 | Hyqvia, Gammagard |
| Axsome Therapeutics, INC. | $84.30 | 2023-2025 | Sunosi, Symbravo |
| Springworks Therapeutics, INC. | $74.70 | 2025 | Gomekli |
| Greenwich Biosciences, INC. | $73.44 | 2019-2021 | |
| Boston Scientific Corporation | $72.67 | 2019-2023 | |
| Janssen Pharmaceuticals, INC | $68.53 | 2021-2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $68.42 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $64.93 | 2021 | |
| Aprecia Pharmaceuticals, LLC | $56.30 | 2022-2023 | Spritam |
| Promius Pharma LLC | $54.10 | 2019 | |
| Avadel Cns Pharmaceuticals, LLC | $51.12 | 2024 | Lumryz |
| Upsher-Smith Laboratories LLC | $49.44 | 2019-2023 | |
| Inspire Medical Systems, INC. | $49.39 | 2023 | Inspire |
| Akcea Therapeutics, INC. | $48.27 | 2020 | |
| Azurity Pharmaceuticals, INC. | $45.92 | 2022-2024 | Zonisade |
| Impel Pharmaceuticals INC. | $41.59 | 2023 | Trudhesa |
| Sanofi-Aventis U.S. LLC | $40.48 | 2019-2020 | |
| Assertio Therapeutics, INC. | $38.79 | 2019-2020 | |
| Kyowa Kirin, INC. | $37.98 | 2019-2024 | Nourianz |
| Ipsen Biopharmaceuticals, INC | $35.12 | 2023-2025 | Dysport |
| Avion Pharmaceuticals | $32.61 | 2023 | Dhivy |
| Merz Pharmaceuticals, LLC | $30.18 | 2025 | Inbrija, Xeomin |
| Horizon Therapeutics Plc | $28.84 | 2023 | Uplizna |
| Mallinckrodt Hospital Products INC. | $27.00 | 2024 | Acthar |
| Bausch Health US, LLC | $25.70 | 2019 | |
| Ge Healthcare | $20.88 | 2024 | |
| Vertos Medical, INC. | $20.20 | 2019 | |
| Cycle Pharmaceuticals INC | $20.12 | 2025 | Tascenso Odt |
| Microtransponder, INC. | $19.39 | 2024 | |
| Corium, LLC | $17.58 | 2023 | Adlarity |
| E.R. Squibb & Sons, L.L.C. | $15.47 | 2021 | |
| Collegium Pharmaceutical, INC. | $13.96 | 2022 | |
| Octapharma USA, INC. | $13.71 | 2025 | Panzyga |
| Astrazeneca Pharmaceuticals LP | $13.23 | 2024 | Wainua |
| Currax Pharmaceuticals LLC | $12.88 | 2021 | |
| Zogenix INC. | $12.60 | 2021 | |
| Almatica Pharma LLC | $12.08 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Sermersheim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.